Fermented Gastrodia elata Blume ameliorates CUMS-induced depression in mice: synergistic regulation of cAMP/BDNF/CREB signaling and gut microbiota-metabolite axis

• The anti-depressant effect of Armillaria gallica fermented GE was investigated. • The content of gastrodin was increased by 3.8 times after fermented by A. gallica. • FG could synergistic regulation of cAMP/BDNF/CREB signaling and gut microbiota-metabolite axis. • FG could be used as a functional food to improve depressive symptoms in the future. Depression is a common mental illness with prolonged periods of low mood that affects billions of people around the world. Gastrodia elata Blume (GE) has the potential value in treating nervous system disease. Nevertheless, the potential antidepressant effects and molecular mechanism of GE that fermented by Armillaria gallica (FG) remain unclear. The aim of this study is to investigate the anti-depressant-like effect and action mechanism of Armillaria gallica fermented Gastrodia elata Blume (FG). The results showed that the content of gastrodin (GAS) and p-hydroxybenzyl alcohol (HBA) were increased by 3.8 and 1 times after fermented by A. gallica . The administration of FG could significantly improve the depressant-like behavior and ameliorate neuronal damage and apoptosis by decreasing the levels of inflammatory factors via the "brain-gut" axis. Meantime, FG could improve the gut microbiota imbalance and increase the richness of beneficial bacteria, Muribaculaceae, Lactobacillus and Desulfovibrio . The serum metabolomics analysis showed that FG can regulate cAMP signaling pathway and tryptophan metabolic pathways to improve depressive symptoms. Notably, the Western blotting results confirmed that the FG could regulate the phosphorylation of CREB and ERK proteins, decrease the NMDAR1, NMDAR2A, and CaMKIIα proteins expression, and increase the NMDAR2B, PSD-95, and Syn1 expression to exerting the anti-depressant effect. In this study, a novel fermentation strategy that could improve the active ingredient content of GE has been developed with significantly anti-depressant-like effects, suggesting that FG could be used as a functional food to improve depressive symptoms in the future.

Authors

Institutions

Publication Details

Journal
Journal of Future Foods
Published
2025-12-01
DOI
https://doi.org/10.1016/j.jfutfo.2025.10.016
Primary Topic
Biological and pharmacological studies of plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fermented Gastrodia elata Blume ameliorates CUMS-induced depression in mice: synergistic regulation of cAMP/BDNF/CREB signaling and gut microbiota-metabolite axis

Qiji Li, Lei Tang, X L Yang, Xiaosheng Yang et al.
Journal of Future Foods
Biological and pharmacological studies of plants
article

Fermented Gastrodia elata Blume ameliorates CUMS-induced depression in mice: synergistic regulation of cAMP/BDNF/CREB signaling and gut microbiota-metabolite axis

Qiji Li, Lei Tang, X L Yang, Xiaosheng Yang, Ming Gao, Xiu Yang
article en

Abstract

• The anti-depressant effect of Armillaria gallica fermented GE was investigated. • The content of gastrodin was increased by 3.8 times after fermented by A. gallica. • FG could synergistic regulation of cAMP/BDNF/CREB signaling and gut microbiota-metabolite axis. • FG could be used as a functional food to improve depressive symptoms in the future. Depression is a common mental illness with prolonged periods of low mood that affects billions of people around the world. Gastrodia elata Blume (GE) has the potential value in treating nervous system disease. Nevertheless, the potential antidepressant effects and molecular mechanism of GE that fermented by Armillaria gallica (FG) remain unclear. The aim of this study is to investigate the anti-depressant-like effect and action mechanism of Armillaria gallica fermented Gastrodia elata Blume (FG). The results showed that the content of gastrodin (GAS) and p-hydroxybenzyl alcohol (HBA) were increased by 3.8 and 1 times after fermented by A. gallica . The administration of FG could significantly improve the depressant-like behavior and ameliorate neuronal damage and apoptosis by decreasing the levels of inflammatory factors via the "brain-gut" axis. Meantime, FG could improve the gut microbiota imbalance and increase the richness of beneficial bacteria, Muribaculaceae, Lactobacillus and Desulfovibrio . The serum metabolomics analysis showed that FG can regulate cAMP signaling pathway and tryptophan metabolic pathways to improve depressive symptoms. Notably, the Western blotting results confirmed that the FG could regulate the phosphorylation of CREB and ERK proteins, decrease the NMDAR1, NMDAR2A, and CaMKIIα proteins expression, and increase the NMDAR2B, PSD-95, and Syn1 expression to exerting the anti-depressant effect. In this study, a novel fermentation strategy that could improve the active ingredient content of GE has been developed with significantly anti-depressant-like effects, suggesting that FG could be used as a functional food to improve depressive symptoms in the future.

Journal of Future Foods
Guiyang Medical University (CN), Guizhou University (CN), Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences (CN)
Openalex Percentile: Top 29%
Biological and pharmacological studies of plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.